Indian Billionaire Dilip Shanghvi s Sun Pharma To Buy U.S. Cancer Drug Maker For 355 Million

Get the Full StorySun Pharmaceutical Industries controlled by Indian billionaire Dilip Shanghvi has agreed to buy U.S.-based immunotherapy and oncology company Checkpoint Therapeutics for 355 million to bolster the Mumbai-based company s drug portfolio.

Share:

More in Business...

Building An Innovation Engine: How To Innovate And Stay Competitive

Russian Propaganda Has Now Infected Western AI Chatbots New Study

Redefining The Customer Journey: A Value-Based Approach To Life And Health Insurance

GenAI Search s Impact On Brand Reputation And How To Control It

How Government Agencies Can Tackle Vendor Exploitation